Genepharm Inc.

Adipo Bioscience is a leading biotechnology company based in Santa Clara, CA, specializing in the development and production of innovative antibody antimicrobial proteins, growth factors, neurotrophins, and soluble receptors for various research areas. With a focus on high sensitivity ELISA and recombinant antibody technologies, Adipo Bioscience offers a wide range of products including protease inhibitors, myokines, adipokines, and MB reagents, catering to the needs of researchers and scientists in the field of bioscience.Generated from the website

SomaGenics develops and provides novel RNA-based gene inhibitors for functional genomics and therapeutics. The company specializes in tools and technologies for drug discovery. It researches inflammatory and autoimmune disorders, HIV and hepatitis C. SomaGenics' primary platform technology is a gene-targeting approach called the RNA Lasso. RNA Lassos have potential applications in drug target discovery, therapeutics, research, and diagnostics. The RNA Lasso platform technology provides a significant advance in addressing diagnostics for research, agricultural, veterinary, food, and medical testing, as well as drug development and discovery. In addition to therapeutic development, SomaGenics has several technology applications available for licensing with partners. The company is based in Santa Cruz, Calif.

Currently, Milagen manufactures and commercializes tissue-based immunodiagnostic products as aid to the pathologist. Milagen offers its product line directly to end-users, and in partnership with diagnostic companies and clinical reference laboratories.